CooP, a linear glioblastoma-targeting nonapeptide, interacts with the mammary-derived growth inhibitor/fatty acid binding protein 3 (FABP3) found in glioblastoma cells and their associated blood vessels. This interaction facilitates the targeted delivery of chemotherapy and various nanoparticles [1].